Cargando…
Markers of Iron Metabolism and Outcomes in Patients with Heart Failure: A Systematic Review
Iron deficiency (ID) in conjunction with heart failure (HF) poses a challenge for clinicians and is associated with worse HF outcomes. Treatment of ID with IV iron supplementation for patients with HF has demonstrated benefits in quality of life (QoL) and HF-related hospitalizations. The aim of this...
Autores principales: | Dhaliwal, Simrat, Kalogeropoulos, Andreas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059277/ https://www.ncbi.nlm.nih.gov/pubmed/36982717 http://dx.doi.org/10.3390/ijms24065645 |
Ejemplares similares
-
Admission NT‐proBNP and outcomes in patients without history of heart failure hospitalized with COVID‐19
por: Yoo, Jeanwoo, et al.
Publicado: (2021) -
Oral iron supplementation in patients with heart failure: a systematic review and meta‐analysis
por: Song, Zhiping, et al.
Publicado: (2022) -
Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
por: Drozd, Marcin, et al.
Publicado: (2016) -
Effects of Intravenous Iron Replacement Therapy on Cardiovascular Outcomes in Patients with Heart Failure: A Systematic Review and Meta-Analysis
por: Reinhold, Johannes, et al.
Publicado: (2023) -
Iron deficiency in heart failure
por: Loncar, Goran, et al.
Publicado: (2021)